LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets
SEARCH
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublications en collaboration avec des chercheurs de Fondazione IRCCS Istituto Nazionale dei Tumori (10)
2021
2020
-
Citrus intake and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)
European Journal of Epidemiology, Vol. 35, Núm. 11, pp. 1057-1067
2019
-
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
2017
-
European position statement on lung cancer screening
The Lancet Oncology, Vol. 18, Núm. 12, pp. e754-e766
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2013
-
A prognostic DNA methylation signature for stage I non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 31, Núm. 32, pp. 4140-4147
2012
-
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort
European Respiratory Journal, Vol. 40, Núm. 1, pp. 177-184
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486